14 Feb Clarity Alzheimer’s Clinical Trial…Ongoing
About this study:
If you or your loved one has early stage Alzheimer’s disease (AD), you may be eligible for this study. This study evaluates the safety and efficacy of BAN2401 in subjects with early Alzheimer’s disease.
Pharmaceutical companies use clinical studies like this to learn more about investigational drugs before they are available to the public. Study volunteers can help us in this important research. Thank you for considering participation in this Clarity Clinical trial.
Who can participate in this study?
To be eligible for this study, you must be:
- 50 to 90 years of age
- Meet criteria for Mild Cognitive Impairment (MCI) or early Alzheimer’s disease
- Have a partner that will accompany you to study visits
What are my costs to take part in this trial?
All tests and procedures that are part of the study and the study visits are provided at no charge to you or your insurance company.
How to get started?
Step 1: Contact our study coordinator, and he/she will give you information and help determine if you qualify.
Step 2: Give Informed Consent. A study doctor will explain the procedures and possible benefits and risks. The study doctor will also answer any questions you may have about the Clarity trial. To join our study, you must read and sign an Informed Consent document to show that you understand the study and what is required of you.
Step 3: Find out if you are eligible. The study staff will ask some health questions and may do a medical evaluation to see if you meet the requirements.